Biotech · Private company · Tenafly, NJ, US

Arma Bio, Inc.

Track this companyFree. Adds Arma Bio, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Development of small molecule therapeutics targeting AR-V7 for prostate cancerFiscal year 2026 · $888.8KNIH RePORTER 5R44CA290913-03 · fetched Nov 12, 2026
Development of small molecule therapeutics targeting AR-V7 for prostate cancerFiscal year 2025 · $1.2MNIH RePORTER 4R44CA290913-02 · fetched Nov 12, 2026
Development of small molecule therapeutics targeting AR-V7 for prostate cancerFiscal year 2024 · $406.5KNIH RePORTER 1R42CA290913-01 · fetched Nov 12, 2026
Development of small molecule therapeutics targeting AR-V7 for prostate cancerFiscal year 2024 · $55KNIH RePORTER 3R42CA290913-01S1 · fetched Nov 12, 2026